EMBO Member
Francis Crick Institute, London | United Kingdom
EMBO 1997
How do signalling systems operate in cancer-associated phenotypes? What are the spatial and temporal constraints operating to influence their behaviour? Can we exploit our developing molecular knowledge of these systems to develop interventions and predictive/pharmacodynamic biomarkers in cancer? Particular interests are around the protein kinase field centred upon the PKC superfamily.
Keywords: Lipid-dependent signalling in cell growth & migration / signal transduction / protein kinases
Subject area(s): Membranes & Transport | Molecular Medicine | Signal Transduction